Aim Bulletin
Secure Trust Bank hails 'strong' start to year
Secure Trust Bank said on Wednesday that it was confident about meeting its full-year targets following a "strong" start to the year.
Oncimmune distributor gets approval for 'EarlyCDT-Lung' in Israel
Immunodiagnostics company Oncimmune Holdings announced on Wednesday that its distributor for Israel, Best Medical Opinion, has received regulatory approval for the sale of the ‘EarlyCDT-Lung’ product in Israel.
Cabot Energy confident despite revenue and production falls
Oil and gas company Cabot Energy updated the market on its financial position, operations and trading for the quarter ended 31 March on Wednesday, reporting a fall in revenue to $2m from $3. 4m year-on-year.
Clinigen to take back US rights to cancer drugs
Aim’s Clinigen Group is taking back control of two oncology drugs from US partner Cumberland Pharmaceuticals.
Mercia's Locate Bio receives another £2m of investment
Technology investment company Mercia Technologies announced on Wednesday that its life sciences direct investment Locate Bio has received an additional £2m of investment.
Armadale Capital makes good progress on Mahenge Liandu study
Natural resources investment company Armadale Capital updated the market on progress on the definitive feasibility study for the Mahenge Liandu Graphite Project on Wednesday, reporting that it was on track to complete in the fourth quarter in 2019.
Serabi Gold sees EBITDA surge in first quarter
Brazil-focussed gold mining and development company Serabi Gold reported a 47% improvement in its EBITDA for its first quarter on Wednesday, to $4. 3m.
Velocys narrows loss after cutting back costs
Velocys on Wednesday cuts its annual losses by slashing its administrative expenses, in part as staff numbers were reduced following the disposal of its UK R&D facility in June 2017.
Elektron sales growth driven by Bulgin and Checkit subsidiaries
Global technology firm Elektron saw sales move ahead in the first quarter of its trading year, boosted by strong sales growth over at its Checkit and Bulgin units.
Yu Group bounds higher after weathering accounting error storm
Yu Group's shares stormed higher on Wednesday after the company reported strong full-year revenue growth and a smaller than expected loss following an accounting review into previously disclosed financial issues.
Strix names Harry Kyriacou as new chief commercial officer
Kettle safety controls designer Strix Group tapped former Glen Dimplex sales director Harry Kyriacou to take over as chief commercial officer on Wednesday.
Be Heard chairman details 'good start' to trading year
Digital marketing outfit Be Heard's chairman David Morrison told investors at the group's annual general meeting on Wednesday that the group had seen a "good start" to the year.
SDI revenues expected to be 'moderately ahead' of expectations
Scientific and technology products manufacturer Scientific Digital Imaging anticipates full-year revenues will be "moderately ahead" of expectations.